Bioanalytical Testing Services Market Forecast To 2033 - Key Opportunities In Specialized Testing For Complex Therapeutics, Driven By Increasing Drug Development, And Regulatory Demand

(MENAFN- GlobeNewsWire - Nasdaq) The bioanalytical testing services market presents key opportunities in specialized testing for complex therapeutics, driven by increasing drug development, regulatory demand, and technological advancements. Growth is supported by AI integration, outsourcing trends, and stringent guidelines enhancing drug safety and efficacy.

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Bioanalytical Testing Services Market Forecast to 2033" has been added to ResearchAndMarkets's offering.

The global bioanalytical testing services market is poised for significant growth in the coming decade. Estimated at USD 4.80 billion in 2024, the market is projected to surge to USD 11.24 billion by 2033, reflecting a robust CAGR of 9.93% from 2025 to 2033.

This trajectory is driven predominantly by expanding drug development activities, complexities in therapeutics, and a rising trend towards outsourcing testing services.

As the development of sophisticated therapeutic modalities such as gene therapies and biologics intensifies, there's an escalating demand for specialized bioanalytical testing services. Concomitantly, technological advancements and R&D investments serve as substantial market growth propellants. Innovations like High-Throughput Screening (HTS), liquid chromatography-mass spectrometry (LC-MS), and Next-generation Sequencing (NGS) have considerably increased the precision and efficiency of bioanalytical testing. Moreover, the incorporation of automation and Artificial Intelligence (AI) into workflows optimizes processes, enhances accuracy, and elevates throughput.

Additionally, heightened regulatory oversight and greater awareness on the significance of bioanalytical testing are bolstering market demand. Stringent guidelines on drug development from global entities such as the U.S. FDA and EMA underscore the requirement for precise and reliable bioanalytical methods, thus propelling a preference for outsourcing. These guidelines are pivotal in ensuring the safety and efficacy of new drugs and biosimilars.

Why You Should Buy This Report

• Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$4.8 Billion
Forecasted Market Value (USD) by 2033	$11.24 Billion
Compound Annual Growth Rate	9.9%
Regions Covered	Global

Companies Featured

• Thermo Fisher Scientific Inc (PPD, Inc.)
• ICON Plc
• Charles River Laboratories International
• IQVIA
• Syneos Health
• SGS SA
• Labcorp
• Intertek Group Plc
• Pace Analytical Services LLC.

Global Bioanalytical Testing Services Market Report Segmentation

Molecule Outlook (Revenue, USD Million, 2021-2033)

• Small Molecule
• Large Molecule
• LC-MS Studies
• Immunoassays
• Other Large Molecule Tests

Test Outlook (Revenue, USD Million, 2021-2033)

• ADME
• In-vivo
• In-vitro
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Bioavailability
• Bioequivalence
• Biomarker Testing
• Cell-based Assay
• Virology Testing
• Other Tests

Workflow Outlook (Revenue, USD Million, 2021-2033)

• Sample Collection and Preparation
• Sample Collection, Handling and Storage
• Protein Precipitation
• Liquid-Liquid Extraction
• Solid Phase Extraction
• Others
• Method Development and Validation
• Sample Analysis
• Hyphenated technique
• Chromatographic technique
• Electrophoresis
• Ligand Binding Assay
• Mass Spectrometry
• Spectroscopic Techniques
• Genomic and Molecular Techniques
• Other processes

End Use Outlook (Revenue, USD Million, 2021-2033)

• Pharma & BioPharma Companies
• CDMO
• CRO
• Others

Regional Outlook (Revenue, USD Million, 2021-2033)

• North America, including U.S., Canada, Mexico
• Europe, covering UK, Germany, France, and others
• Asia-Pacific, featuring Japan, China, India, among others
• Latin America with focus on Brazil, Argentina, Colombia
• Middle East & Africa, including South Africa, Saudi Arabia, UAE

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Bioanalytical Testing Services Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15012026004107003653ID1110603839